-
Best Stocks: Regado Biosciences (NASDAQ:RGDO), Regions Financial Corporation (NYSE:RF), Cvent (NYSE:CVT), Boyd Gaming Corporation (NYSE:BYD), Towerstream Corporation (NASDAQ:TWER)
On Thursday shares of Regado Biosciences, Inc. (NASDAQ:RGDO) closed at $1.21. Announced May 04, Tobira Therapeutics Completes Financing and Merger with Regado Biosciences, Inc. (NASDAQ:RGDO). Newly NASDAQ-Listed TBRA Has Approximately $70 Million to Complete NASH Phase 2b Study and Build Multi-Indication Platform with Cenicriviroc. Regions Financial Corporation (NYSE:RF) in last trading activity decreased -0.68% to…
-
Trader’s Watch List: Regado Biosciences (NASDAQ:RGDO), AbbVie Inc. (NYSE:ABBV), Oracle Corporation (NYSE:ORCL), Ultratech (NASDAQ:UTEK), Spirit Realty Capital (NYSE:SRC)
On Thursday shares of Regado Biosciences, Inc. (NASDAQ:RGDO) closed at $1.29. Regado Biosciences, Inc. (NASDAQ:RGDO) announced presentations of new data for cenicriviroc (CVC) at “The International Liver Congress,” a conference organized by the European Association for the Study of the Liver (EASL). The conference is being held April 22-26 in Vienna, Austria. AbbVie Inc. (NYSE:ABBV)…
-
Morning Alert: Lion Biotechnologies (NASDAQ:LBIO), Regado Biosciences (NASDAQ:RGDO), Denbury Resources Inc. (NYSE:DNR), Southwest Bancorp Inc. (NASDAQ:OKSB), McGrath Rentcorp (NASDAQ:MGRC)
On Tuesday shares of Lion Biotechnologies, Inc. (NASDAQ:LBIO) closed at $12.23. On March 08, Lion Biotechnologies (NASDAQ:LBIO) announced that data from a metastatic cervical cancer study conducted by the National Cancer Institute (NCI) was published in the Journal of Clinical Oncology in an article titled “Complete Regression of Metastatic Cervical Cancer After Treatment With Human…
-
Hot Watch List: Regado Biosciences (NASDAQ:RGDO), ENGlobal Corp. (NASDAQ:ENG), Manning & Napier (NYSE:MN), Alcoa Inc. (NYSE:AA), Newcastle Investment Corp. (NYSE:NCT)
On Thursday shares of Regado Biosciences, Inc. (NASDAQ:RGDO) closed at $1.50. Zacks lowered shares of Regado Biosciences, Inc. (NASDAQ:RGDO) from an outperform rating to a neutral rating in a report released on Monday. Zacks currently has $1.40 price objective on the stock. ENGlobal Corp. (NASDAQ:ENG) in last trading activity moved up 2.33% to close at…
-
News Buzz: Regado Biosciences (NASDAQ:RGDO), CenturyLink (NYSE:CTL), Immunomedics Inc. (NASDAQ:IMMU), Select Comfort Corporation (NASDAQ:SCSS), BIND Therapeutics (NASDAQ:BIND)
On Tuesday shares of Regado Biosciences, Inc. (NASDAQ:RGDO) closed at $1.46. Regado Biosciences, Inc. (NASDAQ:RGDO) currently has a Zacks Rank #3 (Hold). CenturyLink, Inc. (NYSE:CTL) in last trading activity increased 1.83% to close at $35.13. Company quarterly performance stands at -5.16%. CenturyLink, Inc. (NYSE:CTL) is -19.87% away from its 52 week high. CenturyLink, Inc. (NYSE:…
-
Active Watch List: Regado Biosciences (NASDAQ:RGDO), Walter Energy (NYSE:WLT), Johnson & Johnson (NYSE:JNJ), Actavis (NYSE:ACT), Northern Oil and Gas (NYSEMKT:NOG)
On March 9, Tobira Therapeutics, Inc., announced that it has completed a $13 million convertible note financing. Tobira and Regado Biosciences (NASDAQ: RGDO) entered into a merger agreement that is expected to close in the second quarter of 2015. On Monday shares of Regado Biosciences, Inc. (NASDAQ:RGDO) closed at $1.48. Walter Energy, Inc. (NYSE:WLT) has…
-
Stay on: Regado Biosciences (NASDAQ:RGDO), Microchip Technology Inc. (NASDAQ:MCHP), CMS Energy Corp. (NYSE:CMS), Credit Suisse Group AG (NYSE:CS), SunEdison (NYSE:SUNE)
Regado Biosciences, Inc. (NASDAQ:RGDO) currently has a Zacks Rank #3 (Hold). On Monday shares of Regado Biosciences, Inc. (NASDAQ:RGDO) closed at $1.51. Microchip Technology Inc. (NASDAQ:MCHP) announced a new family of 3V Serial Quad I/O interface (or SQI interface) SuperFlash® memory devices—the SST26VF. This three-member “26 Series” SQI interface family is available with 16-Mbit, 32-Mbit…
-
Market Watch List: Pharmacyclics Inc. (NASDAQ:PCYC), Regado Biosciences (NASDAQ:RGDO), Media General (NYSE:MEG), MFA Financial (NYSE:MFA), Petroleo Brasileiro Petrobras (NYSE:PBR)
Harwood Feffer LLP is investigating potential claims against the board of directors of Pharmacyclics, Inc. (NASDAQ:PCYC) concerning the proposed acquisition of the Company by AbbVie Inc. (“AbbVie”). On Thursday shares of Pharmacyclics Inc. (NASDAQ:PCYC) closed at $254.22. Company’s sales growth for last 5 years was 139.30% and EPS growth for next 5 years is recorded…
-
Hot Runners: Regado Biosciences (NASDAQ:RGDO), Delta Air Lines (NYSE:DAL), Cisco Systems (NASDAQ:CSCO), IHS Inc. (NYSE:IHS), Cytori Therapeutics (NASDAQ:CYTX)
Analysts at Zacks downgraded shares of Regado Biosciences, Inc. (NASDAQ:RGDO) from an “outperform” rating to a “neutral” rating and set a $1.40 price target on the stock in a research note on Monday, February 23rd. On Monday shares of Regado Biosciences, Inc. (NASDAQ:RGDO) closed at $1.20. Delta Air Lines, Inc. (NYSE:DAL) is challenging the Obama…
-
Biotech Losers: Xenoport (NASDAQ:XNPT), Onconova Therapeutics (NASDAQ:ONTX), Advaxis (NASDAQ:ADXS), Regado Biosciences (NASDAQ:RGDO), Omeros Corporation (NASDAQ:OMER)
XenoPort, Inc. (NASDAQ: XNPT) on 29 January announced the pricing of $100 million aggregate principal amount of 2.50% Convertible Senior Notes due 2022 in a private placement to qualified institutional buyers pursuant to Rule 144A (the “offering”) under the Securities Act of 1933, as amended (the “Securities Act”). In connection with the offering, XenoPort also…